toosendanin has been researched along with Colorectal Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, F; Gao, L; Huang, W; Li, X; Tao, Z; Xu, S; Ye, Y; Zhang, M | 1 |
| Chen, J; Chen, S; He, L; Huang, L; Li, W; Liu, H; Liu, R; Wang, F; Wang, H; Wen, C; Yang, X; Yu, WK; Zhou, Q | 1 |
| Chu, SJ; Feng, CC; Lu, YM; Wang, G; Zhang, J; Zhang, R; Zhu, JS | 1 |
3 other study(ies) available for toosendanin and Colorectal Neoplasms
| Article | Year |
|---|---|
Toosendanin inhibits colorectal cancer cell growth through the Hedgehog pathway by targeting Shh.
Topics: Apoptosis; Cell Line, Tumor; Colorectal Neoplasms; Drugs, Chinese Herbal; Hedgehog Proteins; Humans; Triterpenes | 2022 |
Toosendanin-induced apoptosis in colorectal cancer cells is associated with the κ-opioid receptor/β-catenin signaling axis.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; beta Catenin; Cell Line, Tumor; Colorectal Neoplasms; Drug Resistance, Neoplasm; Drugs, Chinese Herbal; Female; Fluorouracil; G1 Phase Cell Cycle Checkpoints; Humans; Mice, Inbred BALB C; Molecular Docking Simulation; Receptors, Opioid, kappa; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2020 |
Toosendanin inhibits growth and induces apoptosis in colorectal cancer cells through suppression of AKT/GSK-3β/β-catenin pathway.
Topics: Animals; Apoptosis; beta Catenin; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Drugs, Chinese Herbal; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Mice; Oncogene Protein v-akt; Signal Transduction | 2015 |